81 related articles for article (PubMed ID: 32994590)
1. Evidence of inequitable use of chemotherapy in New Zealand colorectal cancer patients.
Lao C; Kuper-Hommel M; Laking G; Chepulis L; Lawrenson R
N Z Med J; 2020 Aug; 133(1520):15-26. PubMed ID: 32994590
[TBL] [Abstract][Full Text] [Related]
2. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis.
Huria T; Palmer S; Beckert L; Williman J; Pitama S
Int J Equity Health; 2018 Feb; 17(1):27. PubMed ID: 29458366
[TBL] [Abstract][Full Text] [Related]
3. Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?
Tin Tin S; Elwood JM; Brown C; Sarfati D; Campbell I; Scott N; Ramsaroop R; Seneviratne S; Harvey V; Lawrenson R
BMC Cancer; 2018 Jan; 18(1):58. PubMed ID: 29310606
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic and age disparities in chemotherapy selection for colorectal cancer.
Obeidat NA; Pradel FG; Zuckerman IH; Trovato JA; Palumbo FB; DeLisle S; Mullins CD
Am J Manag Care; 2010 Jul; 16(7):515-22. PubMed ID: 20645667
[TBL] [Abstract][Full Text] [Related]
5. Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study.
Seneviratne S; Campbell I; Scott N; Kuper-Hommel M; Round G; Lawrenson R
BMC Cancer; 2014 Nov; 14():839. PubMed ID: 25406582
[TBL] [Abstract][Full Text] [Related]
6. Ethnic differences in disease presentation of uterine cancer in New Zealand women.
Firestone RT; Ellison-Loschmann L; Shelling AN; Ekeroma A; Ikenasio-Thorpe BA; Pearce N; Jeffreys M
J Fam Plann Reprod Health Care; 2012 Oct; 38(4):239-45. PubMed ID: 22241766
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer characteristics and survival differences between Maori, Pacific and other New Zealand women included in the Quality Audit program of Breast Surgeons of Australia and New Zealand.
Campbell I; Scott N; Seneviratne S; Kollias J; Walters D; Taylor C; Roder D
Asian Pac J Cancer Prev; 2015; 16(6):2465-72. PubMed ID: 25824782
[TBL] [Abstract][Full Text] [Related]
8. Colorectal Cancer Screening: How Health Gains and Cost-Effectiveness Vary by Ethnic Group, the Impact on Health Inequalities, and the Optimal Age Range to Screen.
McLeod M; Kvizhinadze G; Boyd M; Barendregt J; Sarfati D; Wilson N; Blakely T
Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1391-1400. PubMed ID: 28626068
[No Abstract] [Full Text] [Related]
9. Ethnicity and management of colon cancer in New Zealand: do indigenous patients get a worse deal?
Hill S; Sarfati D; Blakely T; Robson B; Purdie G; Dennett E; Cormack D; Dew K; Ayanian JZ; Kawachi I
Cancer; 2010 Jul; 116(13):3205-14. PubMed ID: 20564634
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.
Kumar R; Jain K; Beeke C; Price TJ; Townsend AR; Padbury R; Roder D; Young GP; Richards A; Karapetis CS
Cancer; 2013 Feb; 119(4):722-8. PubMed ID: 22990939
[TBL] [Abstract][Full Text] [Related]
11. Patients' expectations about effects of chemotherapy for advanced cancer.
Weeks JC; Catalano PJ; Cronin A; Finkelman MD; Mack JW; Keating NL; Schrag D
N Engl J Med; 2012 Oct; 367(17):1616-25. PubMed ID: 23094723
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer.
Vijayvergia N; Li T; Wong YN; Hall MJ; Cohen SJ; Dotan E
Cancer; 2016 Oct; 122(20):3191-3198. PubMed ID: 27379436
[TBL] [Abstract][Full Text] [Related]
13. Cancer in Māori: lessons from prostate, colorectal and gastric cancer and progress in hereditary stomach cancer in New Zealand.
Blair V; Kahokehr A; Sammour T
ANZ J Surg; 2013 Jan; 83(1-2):42-8. PubMed ID: 23279256
[TBL] [Abstract][Full Text] [Related]
14. Widening ethnic mortality disparities in New Zealand 1981-99.
Blakely T; Tobias M; Robson B; Ajwani S; Bonné M; Woodward A
Soc Sci Med; 2005 Nov; 61(10):2233-51. PubMed ID: 16005132
[TBL] [Abstract][Full Text] [Related]
15. A cohort study of ethnic differences in use of adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand.
Seneviratne S; Campbell I; Scott N; Lawrenson R
BMC Health Serv Res; 2017 Jan; 17(1):64. PubMed ID: 28109301
[TBL] [Abstract][Full Text] [Related]
16. The characteristics and outcomes of patients with colorectal cancer in New Zealand, analysed by Cancer Network.
Blackmore T; Lao C; Chepulis L; Page B; Lawrenson R
N Z Med J; 2020 Apr; 133(1513):42-52. PubMed ID: 32325467
[TBL] [Abstract][Full Text] [Related]
17. The contribution of avoidable mortality to the life expectancy gap in Māori and Pacific populations in New Zealand-a decomposition analysis.
Walsh M; Grey C
N Z Med J; 2019 Mar; 132(1492):46-60. PubMed ID: 30921311
[TBL] [Abstract][Full Text] [Related]
18. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study.
Zanders MM; van Steenbergen LN; Haak HR; Rutten HJ; Pruijt JF; Poortmans PM; Lemmens VE; van de Poll-Franse LV
Diabet Med; 2013 Oct; 30(10):1181-8. PubMed ID: 23758334
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: a cohort study.
Seneviratne S; Lawrenson R; Scott N; Kim B; Shirley R; Campbell I
PLoS One; 2015; 10(4):e0123523. PubMed ID: 25849101
[TBL] [Abstract][Full Text] [Related]
20. Ethnic differences in the management of lung cancer in New Zealand.
Stevens W; Stevens G; Kolbe J; Cox B
J Thorac Oncol; 2008 Mar; 3(3):237-44. PubMed ID: 18317065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
